# Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During Pregnancy

> **NCT02039362** · PHASE4 · COMPLETED · sponsor: **Hopital Lariboisière** · enrollment: 37 (actual)

## Conditions studied

- Pregnancy
- HBV

## Interventions

- **DRUG:** Tenofovir DF

## Key facts

- **NCT ID:** NCT02039362
- **Lead sponsor:** Hopital Lariboisière
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2016-01
- **Final completion:** 2016-07
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2017-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02039362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02039362, "Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During Pregnancy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02039362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*